Cargando…
Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
BACKGROUND: Systemic lupus erythematosus (SLE), is a heterogeneous disease which predominantly affects young females (90%). SLE is associated with a shorter life expectancy than in the general population. Standardized mortality ratios (SMR) of 2.4 have been reported, which is comparable to diabetes....
Autores principales: | Gustafsson, Johanna T., Herlitz Lindberg, Marie, Gunnarsson, Iva, Pettersson, Susanne, Elvin, Kerstin, Öhrvik, John, Larsson, Anders, Jensen-Urstad, Kerstin, Svenungsson, Elisabet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393555/ https://www.ncbi.nlm.nih.gov/pubmed/28414714 http://dx.doi.org/10.1371/journal.pone.0174572 |
Ejemplares similares
-
Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study
por: Nordin, Annica, et al.
Publicado: (2013) -
Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations
por: Mobarrez, Fariborz, et al.
Publicado: (2016) -
IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017) -
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
por: Samuelsson, Isak, et al.
Publicado: (2021) -
ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
por: Nicolai, Sara, et al.
Publicado: (2019)